Revenue from contracts with customers

12 Months Ended

Dec. 31, 2024

Revenue from contracts with customers [Abstract]

Revenue from contracts with customers

4. Revenue from contracts with customers

Disaggregation of revenue from contracts with customers.

The Group derives revenue from the sale and transfer of goods and services over time and at a point in time under the following major business activities:

			2024		2023		2022
	Recognition	Operating segment	A$’000		A$’000		A$’000
Sale of goods	At a point in time	Precision Medicine		770,944		496,310		155,984
Royalty income	At a point in time	Precision Medicine		151		392		385
Provision of services	Over time	Manufacturing Solutions		2,750		418		-
Licenses of intellectual property	Over time	Therapeutics		-		100		374
Research and development services	Over time	Precision Medicine		11		36		-
Research and development services	Over time	Therapeutics		9,351		5,291		3,353
Total revenue from continuing operations				783,207		502,547		160,096